{
  "id": "everyday#screening_cues_59725c3e",
  "title_en": "General — Screening Cues",
  "title_vi": "General — Dấu hiệu sàng lọc",
  "text_en": "156 IMP IMPLEMENTATION OF mhGAP-IG 16. Monitoring & Evaluation Monitoring and Evaluation (M&E) can provide information about Evaluate the mhGAP-IG implementation process, identify There are four main groups of medications that target priority whether a programme is making a difference and for whom; it can successes as well as needs for improvement and update the MNS conditions mentioned in this guide: identify programme areas that are on target or aspects of a pro- situation analysis. antipsychotics for psychotic disorders; gramme that need to be adjusted. Information gained from M&E can demonstrate to programme implementers and funders that drugs used in mood disorders (depressive or bipolar); In addition to the six actions described above, there are three their investments are paying off. M&E provides vital information continuous activities that form an essential part of mhGAP-IG anticonvulsants/antiepileptics; for learning from past experiences, improving service delivery, implementation. These are described in the sections below. planning, resource allocation and demonstrating results as part medications used for management of substance withdrawal, of accountability to key stakeholders. The phrase, “what gets intoxication or dependence . A. PROVISION OF TREATMENT AND CARE: measured gets done,” summarises the importance of monitoring The experiences of many countries demonstrate that & evaluation in programme planning and implementation. The mhGAP-IG recommends a number of pharmacological and improvements in the supply and use of medicines are possible. psychological interventions be provided by non-specialised health Access of populations to essential medicines are determined by: M&E involves planning, coordinating, collecting, analysing care providers. It recommends, for example, problem solving (i) a rational selection of medicines; (ii) making prices affordable; and using data from national, district and local levels, including therapy (PST) and Interpersonal Therapy (IPT) for adult depression. (iii) ensuring sustainable financing; and (iv) availability of reliable health facilities and mhGAP-IG facilitators, trainees and super- WHO has developed psychological interventions in simplified health and supply systems. visors; therefore, it will be helpful if the mhGAP-IG implemen- form. These are scalable interventions and their delivery requires tation team appoints a M&E coordinator or sub-committee a less intense level of specialist human resource use. It means to plan and carry this out. that the intervention has been modified to use fewer resources B. ADVOCACY AND AWARENESS RAISING: compared with conventional psychological interventions and that Some examples of indicators that can be used to monitor people with and without previous training in mental health care Mental health advocacy uses information in deliberate and mhGAP-IG implementation are: facility-level indicators, e.g. number can effectively deliver low-intensity versions of PST and IPT as strategic ways to influence others to create change. It involves of non-specialist health care providers trained on mhGAP-IG, long as they are trained and supervised. Examples of WHO the promotion of the needs and rights of people with mental number of support and supervisory visits to each health facility scalable psychological interventions manuals which are part of disorders, as well as that of the general population. Advocacy is implementing mhGAP-IG; and system-level indicators, e.g. number the mhGAP package include: the WHO Problem Management different from education. Education informs and helps create of health facilities using mhGAP-IG to assess and manage persons Therapy PM+ manual, the WHO Interpersonal Therapy manual understanding of an issue. Advocacy, on the other hand, aims to with MNS conditions, number of health facilities with an (IPT), the WHO Thinking Healthy manual for maternal depression, persuade. This is done through requests",
  "gloss_vi": "156 imp implementation of mhgap-ig 16. monitoring & evaluation monitoring and evaluation (m&e) can provide information about evaluate the mhgap-ig implementation process, identify there are four main groups of medication...",
  "source": "Everyday Essentials",
  "url": "",
  "lang": "en",
  "axes": {
    "type": [
      "clinical",
      "everyday"
    ],
    "condition": [
      "General"
    ],
    "clinical_section": [
      "screening_cues",
      "referral",
      "psychoeducation"
    ],
    "life_topics": [
      "study"
    ],
    "advice_section": [],
    "audience": [],
    "risk_band": "low"
  },
  "index_text": "General — Screening Cues General — Dấu hiệu sàng lọc 156 IMP IMPLEMENTATION OF mhGAP-IG 16. Monitoring & Evaluation Monitoring and Evaluation (M&E) can provide information about Evaluate the mhGAP-IG implementation process, identify There are four main groups of medications that target priority whether a programme is making a difference and for whom; it can successes as well as needs for improvement and update the MNS conditions mentioned in this guide: identify programme areas that are on target or aspects of a pro- situation analysis. antipsychotics for psychotic disorders; gramme that need to be adjusted. Information gained from M&E can demonstrate to programme implementers and funders that drugs used in mood disorders (depressive or bipolar); In addition to the six actions described above, there are three their investments are paying off. M&E provides vital information continuous activities that form an essential part of mhGAP-IG anticonvulsants/antiepileptics; for learning from past experiences, improving service delivery, implementation. These are described in the sections below. planning, resource allocation and demonstrating results as part medications used for management of substance withdrawal, of accountability to key stakeholders. The phrase, “what gets intoxication or dependence . A. PROVISION OF TREATMENT AND CARE: measured gets done,” summarises the importance of monitoring The experiences of many countries demonstrate that & evaluation in programme planning and implementation. The mhGAP-IG recommends a number of pharmacological and improvements in the supply and use of medicines are possible. psychological interventions be provided by non-specialised health Access of populations to essential medicines are determined by: M&E involves planning, coordinating, collecting, analysing care providers. It recommends, for example, problem solving (i) a rational selection of medicines; (ii) making prices affordable; and using data from national, district and local levels, including therapy (PST) and Interpersonal Therapy (IPT) for adult depression. (iii) ensuring sustainable financing; and (iv) availability of reliable health facilities and mhGAP-IG facilitators, trainees and super- WHO has developed psychological interventions in simplified health and supply systems. visors; therefore, it will be helpful if the mhGAP-IG implemen- form. These are scalable interventions and their delivery requires tation team appoints a M&E coordinator or sub-committee a less intense level of specialist human resource use. It means to plan and carry this out. that the intervention has been modified to use fewer resources B. ADVOCACY AND AWARENESS RAISING: compared with conventional psychological interventions and that Some examples of indicators that can be used to monitor people with and without previous training in mental health care Mental health advocacy uses information in deliberate and mhGAP-IG implementation are: facility-level indicators, e.g. number can effectively deliver low-intensity versions of PST and IPT as strategic ways to influence others to create change. It involves of non-specialist health care providers trained on mhGAP-IG, long as they are trained and supervised. Examples of WHO the promotion of the needs and rights of people with mental number of support and supervisory visits to each health facility scalable psychological interventions manuals which are part of disorders, as well as that of the general population. Advocacy is implementing mhGAP-IG; and system-level indicators, e.g. number the mhGAP package include: the WHO Problem Management different from education. Education informs and helps create of health facilities using mhGAP-IG to assess and manage persons Therapy PM+ manual, the WHO Interpersonal Therapy manual understanding of an issue. Advocacy, on the other hand, aims to with MNS conditions, number of health facilities with an (IPT), the WHO Thinking Healthy manual for maternal depression, persuade. This is done through requests 156 imp implementation of mhgap-ig 16. monitoring & evaluation monitoring and evaluation (m&e) can provide information about evaluate the mhgap-ig implementation process, identify there are four main groups of medication..."
}